Systemic lupus erythematosus-associated pulmonary hypertension: Good outcome following sildenafil therapy
10.1191/0961203303lu324cr
Molina J, Lucero E, Luluaga S (2003) Systemic lupus erythematosus-associated pulmonary hypertension: Good outcome following sildenafil therapy. Lupus 12:321-323 10.1191/0961203303lu324cr
Management of pulmonary hypertension resulting from interstitial lung disease
10.1097/00063198-200309000-00015
Shelley S (2003) Management of pulmonary hypertension resulting from interstitial lung disease. Curr Opin Pulm Med 9:426-430 10.1097/ 00063198-200309000-00015
Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension
1:CAS:528:DC%2BD3MXnsV2mt7w%3D
Wilkens H, Guth A, König J (2001) Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension. Circulation 104:1218-1222 1:CAS:528:DC%2BD3MXnsV2mt7w%3D
Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension
10.1136/heart.84.2.e4
Abrams D, Schulze-Neick I, Magee AG (2000) Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension. Heart 84:E4 10.1136/heart.84.2.e4
Long-term treatment with oral sildenafil in a thalassemic patient with pulmonary hypertension
10.1182/blood-2002-04-1171
Littera R, La Nasa G, Derchi G (2002) Long-term treatment with oral sildenafil in a thalassemic patient with pulmonary hypertension. Blood 100:1516-1517 10.1182/blood-2002-04-1171
Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial
10.1016/S0140-6736(02)11024-5
Ghofrani H, Wiedemann R, Rose F (2002) Sildenafil for treatment of lung fibrosis and pulmonary hypertension: A randomised controlled trial. Lancet 360:895-900 10.1016/S0140-6736(02)11024-5